Breaking News Instant updates and real-time market news.

INGN

Inogen

$98.19

1.69 (1.75%)

17:19
08/03/17
08/03
17:19
08/03/17
17:19

Inogen raises FY17 revenue view to $239M-$243M from $233M-$239M

Consensus $238.31M. Inogen is increasing its guidance range for full year 2017 revenue to $239 to $243 million, which represents year-over-year growth of 17.8% to 19.8%, and compares to previous guidance of $233 to $239 million. The Company expects direct-to-consumer sales and domestic business-to-business sales to be our strongest growing channels and to have similar growth rates, and international business-to-business sales to have a more modest growth rate where the market penetration strategy is expected to be primarily focused on the European markets. Inogen expects rental revenue to decline in 2017 compared to 2016 by approximately 30% based on lower average rental revenue per patient and a focus on sales versus rentals. Inogen is increasing its guidance range for full year 2017 net income and Adjusted net income to $25 to $27 million, which represents 21.8% to 31.6% year-over-year growth, and compares to previous guidance of $22 to $24 million. Inogen estimates that the adoption of ASU No. 2016-09 will lead to a decrease in provision for income taxes of approximately $8.0 million in 2017 based on forecasted stock activity, which will continue to lower its effective tax rate. Excluding the $8.0 million decrease in provision for income taxes expected in 2017, the Company expects an effective tax rate of approximately 36% compared to its previous expectations of 37%. After giving effect to ASU No. 2016-09, the Company expects an effective tax rate including stock compensation deductions to vary quarter-to-quarter depending on the amount of pre-tax net income and on the timing and size of stock option exercises. Inogen is narrowing its guidance range for full year 2017 Adjusted EBITDA to $48 to $50 million, which represents year-over-year growth of 10.6% to 15.2%, and compares to previous guidance of $46 to $50 million.

  • 03

    Aug

INGN Inogen
$98.19

1.69 (1.75%)

03/27/17
LEER
03/27/17
NO CHANGE
Target $90
LEER
Outperform
Inogen well-positioned to deliver "beat/raise" quarters, says Leerink
After hosting meetings with Inogen's CEO Scott Wilkinson and CFO Ali Bauerlein, Leerink analyst Danielle Antalffy is "even more confident" that the company remains on track to build upon its "solid" history of execution since becoming a public company, and is well-positioned to continue to deliver consistent "beat and raise" quarters. In the near-term, the analyst sees room for potential upside to Inogen's 2017 guidance given a steady adoption trend among homecare providers and management's conservative approach to issuing guidance for the lower visibility B2B businesses. She reiterates an Outperform rating and $90 price target on the shares.
04/18/17
SIDC
04/18/17
INITIATION
SIDC
Neutral
Inogen initiated with a Neutral at Sidoti
05/10/17
NEED
05/10/17
NO CHANGE
Target $96
NEED
Strong Buy
Inogen price target raised to $96 from $83 at Needham
Needham analyst Mike Matson raised his price target for Inogen to $96 from $83 after the company beat consensus revenue, EBITDA, and EPS in Q1. The analyst continues to view guidance as conservative and expects Inogen's revenue growth to increase due to the ongoing G4 launch and easier comps as it laps the Medicare reimbursement cuts in 2H17. He reiterates a Strong Buy rating on the shares.
06/26/17
JPMS
06/26/17
NO CHANGE
Target $102
JPMS
Overweight
Inogen price target raised to $102 from $92 at JPMorgan
JPMorgan analyst Robbie Marcus raised his price target for Inogen to $102 after hosting management for investor meetings. The analyst believes the company's recent trends are "strong" and he views consensus expectations as "overly conservative." Inogen management believes their competitive lead has never been greater, Marcus tells investors in a research note. The analyst keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

SIRI

SiriusXM

$5.40

0.02 (0.37%)

12:45
11/17/17
11/17
12:45
11/17/17
12:45
Options
Sirius XM call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
11/17/17
11/17
12:45
11/17/17
12:45
General news
Breaking General news story  »

Week of 11/17…

FL

Foot Locker

$39.80

7.95 (24.96%)

12:32
11/17/17
11/17
12:32
11/17/17
12:32
Upgrade
Foot Locker rating change  »

Deutsche sees sustained…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

XRT

S&P Retail Index SPDR

$41.59

0.98 (2.41%)

12:30
11/17/17
11/17
12:30
11/17/17
12:30
Options
Defensive short-term play in SPDR Retail ETF »

Defensive short-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
11/17/17
11/17
12:30
11/17/17
12:30
General news
Breaking General news story  »

San Francisco Federal…

FTI

TechnipFMC

$26.72

0.175 (0.66%)

12:25
11/17/17
11/17
12:25
11/17/17
12:25
Options
FMC Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$NSD

NASDAQ Market Internals

12:17
11/17/17
11/17
12:17
11/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$11.25

0.18 (1.63%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Options
AMD calls outpace puts 4:1 as shares advance »

AMD calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TSLA

Tesla

$312.50

1.2 (0.39%)

, AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Hot Stocks
Tesla, Amazon look to shake up trucking industry with new vehicle, app »

Shares of third-party…

TSLA

Tesla

$312.50

1.2 (0.39%)

AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

CHRW

C.H. Robinson

$80.40

0.45 (0.56%)

LSTR

Landstar System

$96.80

1.75 (1.84%)

XPO

XPO Logistics

$74.29

0.1035 (0.14%)

JBHT

J.B. Hunt

$102.98

1.44 (1.42%)

WMT

Wal-Mart

$96.94

-2.68 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 28

    Nov

  • 07

    Dec

  • 11

    Dec

  • 09

    Jan

  • 16

    Jan

  • 20

    Feb

  • 18

    Mar

$NYE

NYSE Market Internals

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$11.36

-0.58 (-4.86%)

12:12
11/17/17
11/17
12:12
11/17/17
12:12
Recommendations
MiMedx analyst commentary  »

MiMedx growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 01

    Dec

XOP

SPDR Oil Exploration and Production Fund

$34.83

0.525 (1.53%)

12:00
11/17/17
11/17
12:00
11/17/17
12:00
Options
Defensive short-term option play in SPDR Oil Exploration and Production ETF »

Defensive short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNK

Teekay Tankers

$1.41

0.01 (0.71%)

11:55
11/17/17
11/17
11:55
11/17/17
11:55
Conference/Events
Teekay Tankers to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

TWX

Time Warner

$88.53

0.52 (0.59%)

, VIA

Viacom

$30.10

-0.65 (-2.11%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Hot Stocks
Box Office Battle: 'Justice League' to vanquish 'Thor' in debut »

The major release opening…

TWX

Time Warner

$88.53

0.52 (0.59%)

VIA

Viacom

$30.10

-0.65 (-2.11%)

VIAB

Viacom

$23.69

-0.92 (-3.74%)

LGF.A

Lionsgate

$32.32

1.28 (4.12%)

LGF.B

Lionsgate

$30.70

1.17 (3.96%)

DIS

Disney

$103.61

0.01 (0.01%)

FOX

21st Century Fox

$28.60

0.65 (2.33%)

FOXA

21st Century Fox

$29.32

0.59 (2.05%)

CMCSA

Comcast

$37.07

-0.11 (-0.30%)

CMCSK

Comcast

SNE

Sony

$46.20

0.1 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANF

Abercrombie & Fitch

$15.49

2.9398 (23.42%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Recommendations
Abercrombie & Fitch analyst commentary  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

HFWA

Heritage Financial

$30.60

0.3 (0.99%)

11:48
11/17/17
11/17
11:48
11/17/17
11:48
Hot Stocks
Heritage Financial, Puget Sound Bancorp deal receives regulatory approvals »

Heritage Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$46.81

0.215 (0.46%)

11:40
11/17/17
11/17
11:40
11/17/17
11:40
Options
108K iShares Emerging Markets Fund Dec 44.5 puts bought for 22c »

108K iShares Emerging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
11/17/17
11/17
11:35
11/17/17
11:35
General news
Euro$ interest rate futures recovered from lows »

Euro$ interest rate…

ANF

Abercrombie & Fitch

$16.00

3.45 (27.49%)

11:31
11/17/17
11/17
11:31
11/17/17
11:31
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

M

Macy's

$20.63

0.38 (1.88%)

11:30
11/17/17
11/17
11:30
11/17/17
11:30
Options
Calendar risk reversal in Macys may roll call gains into put protection »

Calendar risk reversal in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ANF

Abercrombie & Fitch

$15.94

3.39 (27.01%)

11:28
11/17/17
11/17
11:28
11/17/17
11:28
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

AAPL

Apple

$171.10

2.02 (1.19%)

11:24
11/17/17
11/17
11:24
11/17/17
11:24
Periodicals
Apple delays release of HomePod to early 2018, TechCrunch reports »

Apple is delaying the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$110.15

-0.87 (-0.78%)

, MA

MasterCard

$148.53

-1.7995 (-1.20%)

11:23
11/17/17
11/17
11:23
11/17/17
11:23
Recommendations
Visa, MasterCard analyst commentary  »

Visa highlights possible…

V

Visa

$110.15

-0.87 (-0.78%)

MA

MasterCard

$148.53

-1.7995 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

GLD

SPDR Gold Trust

$122.32

0.92 (0.76%)

11:20
11/17/17
11/17
11:20
11/17/17
11:20
Options
Far downside put buyers in SPDR Gold ETF as the metal trades higher »

Far downside put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
11/17/17
11/17
11:17
11/17/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.